tradingkey.logo
tradingkey.logo
Pesquisar

Bio Rad Laboratories Inc

BIO
Adicionar à lista de desejos
243.510USD
+1.800+0.74%
Fechamento 05/13, 16:00ETCotações atrasadas em 15 min
6.57BValor de mercado
40.38P/L TTM

Bio Rad Laboratories Inc

243.510
+1.800+0.74%

Mais detalhes de Bio Rad Laboratories Inc Empresa

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Informações de Bio Rad Laboratories Inc

Código da empresaBIO
Nome da EmpresaBio Rad Laboratories Inc
Data de listagemMar 17, 1980
CEOSchwartz (Norman D)
Número de funcionários7700
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 17
Endereço1000 Alfred Nobel Dr
CidadeHERCULES
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal94547
Telefone15107247000
Sitehttps://www.bio-rad.com/
Código da empresaBIO
Data de listagemMar 17, 1980
CEOSchwartz (Norman D)

Executivos da empresa Bio Rad Laboratories Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+82.48%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
715.00
+56.92%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
715.00
+56.92%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
308.00
--
Rajat Mehta
Rajat Mehta
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
58.00
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.38M
-1.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
1.22K
+33.50%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+82.48%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
721.00
+15.12%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.02B
39.59%
Europe
881.80M
34.14%
APAC
513.30M
19.87%
Other
165.40M
6.40%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
First Eagle Investment Management, L.L.C.
11.85%
Alice N. Schwartz Revocable Trust
8.21%
BlackRock Institutional Trust Company, N.A.
6.73%
Schwartz (Norman D)
6.36%
Dimensional Fund Advisors, L.P.
5.02%
Outro
61.84%
Investidores
Investidores
Proporção
First Eagle Investment Management, L.L.C.
11.85%
Alice N. Schwartz Revocable Trust
8.21%
BlackRock Institutional Trust Company, N.A.
6.73%
Schwartz (Norman D)
6.36%
Dimensional Fund Advisors, L.P.
5.02%
Outro
61.84%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
44.15%
Investment Advisor
40.11%
Individual Investor
8.27%
Corporation
8.21%
Hedge Fund
4.12%
Research Firm
2.06%
Pension Fund
1.08%
Bank and Trust
0.89%
Sovereign Wealth Fund
0.53%

Participação acionária institucional

Atualizado em: dom, 5 de abr
Atualizado em: dom, 5 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
1041
18.42M
84.86%
-4.19M
2025Q4
1040
20.58M
101.60%
-3.97K
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
First Eagle Investment Management, L.L.C.
2.57M
11.72%
+50.15K
+1.99%
Dec 31, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.13%
--
--
Feb 23, 2026
BlackRock Institutional Trust Company, N.A.
1.46M
6.66%
-23.75K
-1.60%
Dec 31, 2025
Schwartz (Norman D)
1.38M
6.3%
-13.77K
-0.99%
Feb 23, 2026
Dimensional Fund Advisors, L.P.
1.08M
4.91%
+14.13K
+1.33%
Dec 31, 2025
Ariel Investments, LLC
764.67K
3.49%
-44.81K
-5.54%
Dec 31, 2025
EARNEST Partners, LLC
603.59K
2.75%
-5.69K
-0.93%
Dec 31, 2025
State Street Investment Management (US)
559.60K
2.55%
-11.99K
-2.10%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
Ver Mais
Parnassus Value Select ETF
Proporção3.94%
First Trust Indxx Medical Devices ETF
Proporção2.15%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.61%
Schwab Ariel Opportunities ETF
Proporção1.6%
First Trust Health Care Alphadex Fund
Proporção1.49%
FPA Global Equity ETF
Proporção1.38%
First Eagle Global Equity ETF
Proporção1.21%
iShares Health Innovation Active ETF
Proporção1.17%
Pacer US Export Leaders ETF
Proporção1.03%
Harbor Health Care ETF
Proporção0.82%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI